Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-11 Sale | 2024-10-15 4:22 pm | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 10,757 | $13.57 | $146,004 | 236,854 (Direct) | View |
| 2024-10-11 Sale | 2024-10-15 4:21 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 15,271 | $13.52 | $206,433 | 895,941 (Direct) | View |
| 2024-07-24 Sale | 2024-07-26 9:45 pm | Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner | 550,000 | $13.05 | $7,177,500 | 8,644,579 (Indirect) | View |
| 2024-07-16 Sale | 2024-07-18 6:34 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 525 | $15 | $7,876 | 286,356 (Direct) | View |
| 2024-07-11 Sale | 2024-07-12 4:37 pm | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 10,757 | $13.14 | $141,394 | 247,611 (Direct) | View |
| 2024-07-11 Sale | 2024-07-12 4:36 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 15,746 | $13.34 | $210,075 | 911,212 (Direct) | View |
| 2024-06-17 Sale | 2024-06-20 5:44 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 49,313 | $12.01 | $592,022 | 926,958 (Direct) | View |
| 2024-06-12 Sale | 2024-06-14 6:15 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 72,797 | $12.7 | $924,203 | 976,271 (Direct) | View |
| 2024-06-11 Sale | 2024-06-13 5:33 pm | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 96,815 | $12.94 | $1,252,718 | 255,462 (Direct) | View |
| 2024-05-09 Sale | 2024-05-10 4:17 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 100 | $15 | $1,500 | 270,051 (Direct) | View |
| 2024-02-12 Purchase | 2024-02-14 9:06 pm | Mineralys Therapeutics Inc. | MLYS | Samsara BioCapital GP LLC Samsara BioCapital L.P. 10% Owner | 555,555 | $13.5 | $7,499,993 | 5,074,916 (Indirect) | View |
| 2023-11-22 Purchase | 2023-11-27 4:01 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 4,250 | $5.9661 | $25,356 | 1,049,068 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-11 Exercise | 2024-10-15 4:22 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 316,460 (Direct) | View |
| 2024-10-14 Exercise | 2024-10-15 4:22 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,352 | $1.08 | 316,460 (Direct) | View |
| 2024-10-11 Exercise | 2024-10-15 4:22 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 10,369 | $0 | 316,460 (Direct) | View |
| 2024-09-11 Exercise | 2024-09-12 4:32 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,018 | $0.54 | 316,460 (Direct) | View |
| 2024-09-12 Exercise | 2024-09-12 4:32 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 316,460 (Direct) | View |
| 2024-09-11 Exercise | 2024-09-12 4:32 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,367 | $0 | 316,460 (Direct) | View |
| 2024-08-12 Exercise | 2024-08-13 4:20 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 316,460 (Direct) | View |
| 2024-08-12 Exercise | 2024-08-13 4:20 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $1.08 | 316,460 (Direct) | View |
| 2024-08-12 Exercise | 2024-08-13 4:20 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,365 | $0 | 316,460 (Direct) | View |
| 2024-07-16 Exercise | 2024-07-18 6:34 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 525 | $1.08 | 286,356 (Direct) | View |
| 2024-07-16 Exercise | 2024-07-18 6:34 pm | N/A 2032-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 525 | $0 | 286,356 (Direct) | View |
| 2024-07-11 Exercise | 2024-07-12 4:39 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 316,985 (Direct) | View |
| 2024-07-12 Exercise | 2024-07-12 4:39 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 316,985 (Direct) | View |
| 2024-07-11 Exercise | 2024-07-12 4:39 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $0 | 316,985 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 4:33 pm | N/A 2034-06-13 | Mineralys Therapeutics Inc. | MLYS | Gold Alexander M Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2024-06-11 Exercise | 2024-06-13 5:32 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 315,207 (Direct) | View |
| 2024-06-12 Exercise | 2024-06-13 5:32 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 315,207 (Direct) | View |
| 2024-06-11 Exercise | 2024-06-13 5:32 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $0 | 315,207 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-28 6:51 pm | N/A 2034-05-22 | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 22,000 | $0 | 22,000 (Indirect) | View |
| 2024-05-22 Option Award | 2024-05-23 4:22 pm | N/A 2034-05-22 | Mineralys Therapeutics Inc. | MLYS | DiRocco Derek Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-23 4:22 pm | N/A 2034-05-22 | Mineralys Therapeutics Inc. | MLYS | SBLENDORIO GLENN Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-23 4:21 pm | N/A 2034-05-22 | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Samsara BioCapital L.P. Director 10% Owner | 22,000 | $0 | 22,000 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-23 4:21 pm | N/A 2034-05-22 | Mineralys Therapeutics Inc. | MLYS | Karydas Daphne Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-23 4:21 pm | N/A 2034-05-22 | Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner | 22,000 | $0 | 22,000 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-23 4:20 pm | N/A 2034-05-22 | Mineralys Therapeutics Inc. | MLYS | Litzka Olivier Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2024-05-13 Exercise | 2024-05-15 4:43 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,018 | $0.54 | 315,207 (Direct) | View |
| 2024-05-13 Exercise | 2024-05-15 4:43 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $1.08 | 315,207 (Direct) | View |
| 2024-05-13 Exercise | 2024-05-15 4:43 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $0 | 315,207 (Direct) | View |
| 2024-05-09 Exercise | 2024-05-10 4:17 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 100 | $1.08 | 270,051 (Direct) | View |
| 2024-05-09 Exercise | 2024-05-10 4:17 pm | N/A 2031-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 100 | $0 | 270,051 (Direct) | View |
| 2024-04-11 Exercise | 2024-04-15 4:24 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 315,307 (Direct) | View |
| 2024-04-12 Exercise | 2024-04-15 4:24 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 315,307 (Direct) | View |
| 2024-04-11 Exercise | 2024-04-15 4:24 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $0 | 315,307 (Direct) | View |
| 2024-03-11 Exercise | 2024-03-13 5:35 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 315,307 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-13 5:35 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $1.08 | 315,307 (Direct) | View |
| 2024-03-11 Exercise | 2024-03-13 5:35 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,365 | $0 | 315,307 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 4:26 pm | N/A 2034-02-13 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 4:26 pm | N/A 2034-02-13 | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 4:26 pm | N/A 2034-02-13 | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 425,000 | $0 | 425,000 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 9:07 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Director 10% Owner | 555,555 | $13.5 | 5,074,916 (Indirect) | View |
| 2024-02-12 Option Award | 2024-02-14 7:49 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 1,672,508 | $13.5 | 5,400,739 (Indirect) | View |
| 2024-02-12 Option Award | 2024-02-14 7:49 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 549,755 | $13.5 | 5,400,739 (Indirect) | View |
| 2024-02-12 Exercise | 2024-02-13 4:08 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 315,307 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-13 4:08 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 315,307 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-13 4:08 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $0 | 315,307 (Direct) | View |
| 2024-01-11 Exercise | 2024-01-12 4:01 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 315,307 (Direct) | View |
| 2024-01-12 Exercise | 2024-01-12 4:01 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $1.08 | 315,307 (Direct) | View |
| 2024-01-11 Exercise | 2024-01-12 4:01 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,365 | $0 | 315,307 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-12 5:08 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,018 | $0.54 | 85,293 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-12 5:08 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,018 | $0 | 85,293 (Direct) | View |
| 2023-11-13 Exercise | 2023-11-14 6:18 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 85,293 (Direct) | View |
| 2023-11-13 Exercise | 2023-11-14 6:18 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0 | 85,293 (Direct) | View |
| 2023-11-03 Exercise | 2023-11-07 5:15 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 10,034 | $0.54 | 85,293 (Direct) | View |
| 2023-11-03 Exercise | 2023-11-07 5:15 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 10,034 | $0 | 85,293 (Direct) | View |